Welcome to CDC Stacks | Clinical Significance of Escherichia albertii - 23836 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Clinical Significance of Escherichia albertii
Filetype[PDF - 314.62 KB]


No Related Documents.
You May Also Like:
  1. Escherichia albertii in Wild and Domestic Birds
    Personal Author:
    Oaks, J. Lindsay; Besser, Thomas E.; Walk, Seth T.; Gordon, David M.; Beckmen, Kimberlee B.; Burek, Kathy A.; Haldorson, Gary J.; Bradway, Dan S.; Ouellette, Lindsey; Rurangirwa, Fred R.; Davis, Margaret A.; Dobbin, Greg; Whittam, Thomas S.;
    Published:
    Apr 2010
    Source:
    Emerg Infect Dis. 16(4):638-646.
    Description:
    Escherichia albertii has been associated with diarrhea in humans but not with disease or infection in animals. However, in December 2004, E. albertii was found, by biochemical and genetic methods, to be the probable cause of death for redpoll finches...
    File Type:
    Filetype[PDF - 846.88 KB]
  2. Clinical Significance of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia1
    Personal Author:
    Schwaber, Mitchell J.; Wright, Sharon B.; Carmeli, Yehuda; Venkataraman, Lata; DeGirolami, Paola C.; Gramatikova, Aneta; Perl, Trish M.; Sakoulas, George; Gold, Howard S.;
    Published:
    Jun 2003
    Source:
    Emerg Infect Dis. 9(6):657-664.
    Description:
    We conducted a retrospective study of the clinical aspects of bacteremia caused by methicillin-resistant Staphylococcus aureus (MRSA) with heterogeneously reduced susceptibility to vancomycin. Bloodstream MRSA isolates were screened for reduced susce...
    File Type:
    Filetype[PDF - 345.00 KB]
  3. Clinical Significance and Epidemiology of NO-1, an Unusual Bacterium Associated with Dog and Cat Bites
    Personal Author:
    Kaiser, Robyn M.; Garman, Robert L.; Bruce, Michael G.; Weyant, Robbin S.; Ashford, David A.;
    Published:
    Feb 2002
    Source:
    Emerg Infect Dis. 8(2):171-174.
    Description:
    From 1974 to 1998, 22 isolates of an unusual bacterium, designated as CDC nonoxidizer 1 group (NO-1), were sent to the Centers for Disease Control and Prevention for identification. The organism's phenotypic characteristics were similar to asaccharol...
    File Type:
    Filetype[PDF - 39.14 KB]
  4. Effects and Clinical Significance of GII.4 Sydney Norovirus, United States, 2012–2013
    Personal Author:
    Leshem, Eyal; Wikswo, Mary; Barclay, Leslie; Brandt, Eric; Storm, William; Salehi, Ellen; DeSalvo, Traci; Davis, Tim; Saupe, Amy; Dobbins, Ginette; Booth, Hillary A.; Biggs, Christianne; Garman, Katie; Woron, Amy M.; Parashar, Umesh D.; Vinjé, Jan; Hall, Aron J.;
    Published:
    Aug 2013
    Source:
    Emerg Infect Dis. 19(8):1231-1238.
    Description:
    During 2012, global detection of a new norovirus (NoV) strain, GII.4 Sydney, raised concerns about its potential effect in the United States. We analyzed data from NoV outbreaks in 5 states and emergency department visits for gastrointestinal illness...
    File Type:
    Filetype[PDF - 660.54 KB]
  5. Human Gastroenteritis Outbreak Associated with Escherichia albertii, Japan
    Personal Author:
    Ooka, Tadasuke; Tokuoka, Eisuke; Furukawa, Masato; Nagamura, Tetsuya; Ogura, Yoshitoshi; Arisawa, Kokichi; Harada, Seiya; Hayashi, Tetsuya;
    Published:
    Jan 2013
    Source:
    Emerg Infect Dis. 19(1):144-146.
    Description:
    Although Escherichia albertii is an emerging intestinal pathogen, it has been associated only with sporadic human infections. In this study, we determined that a human gastroenteritis outbreak at a restaurant in Japan had E. albertii as the major cau...
    File Type:
    Filetype[PDF - 679.52 KB]